109 completed, 9 terminated, 8 active not recruiting, 6 recruiting. 48 Phase 3, 33 Phase 2, 28 Phase 1, 22 Phase 4, 10 Not applicable.
Follow Tetanus Toxoid: new trials by email Literature Review of Tetanus Toxoid trials Research Report on Tetanus Toxoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine+Inactivated Poliomyelitis Vaccine Made From Sabin Strains - Diphtheria, Pertussis | Phase 1 / Phase 2 | Recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 380 | 2026-10-11 | 2026-10-23 |
| ESCUDDO Long Term Follow Up Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Recombinant Human Papillomavirus Nonavalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Malignant Neoplasm | Phase 4 | Enrolling by invitation | National Cancer Institute (NCI) | 13700 | 2026-08-11 | 2026-09-22 |
| Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid) 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) (referred to as PCV24) (dose M), PCV24 vaccine (dose H), PCV24 vaccine (dose M) - Streptococcus Pneumoniae Infection | Phase 1 / Phase 2 | Recruiting | CanSino Biologics Inc. | 854 | 2026-05-24 | 2026-08-05 |
| Phase I Clinical Trial of Adsorbed Tetanus Vaccine Tetanus Vaccine, Adsorbed - Tetanus | Phase 1 | Active not recruiting | Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | 80 | 2026-05-21 | 2026-09-22 |
| Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine low-dose Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (Reduced Antigens Content), high-dose Tetanus, Diphtheria and Acellular Component Pertussis Vaccine Adsorbed (Reduced Antigens Content), Tetanus, Diphtheria and Acellular Pertussis Vaccine - Tetanus, Diphtheria and Acellular Pertussis Vaccination, Tetanus | Phase 1 / Phase 2 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 660 | 2026-03-12 | 2026-02-18 |
| Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children AltSonflex1-2-3, Menveo, Infanrix hexa - Diarrhoea | Phase 2 | Not yet recruiting | GlaxoSmithKline | 528 | 2026-01-02 | 2026-01-06 |
| Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines trivalent inactivated influenza vaccine (TIV), nonavalent HPV vaccine (HPV), hepatitis A (HAV) vaccines - Immunology, Healthy Adults | Phase 4 | Active not recruiting | Washington University School of Medicine | 25 | 2025-08-26 | 2026-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants SNA02-48, Placebo, HTIG - Tetanus | Phase 1 / Phase 2 | Completed | Sinovac Life Sciences Co., Ltd. | 255 | 2025-04-28 | 2026-06-03 |
| Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 1), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 2), Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP Lot 3) - Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Active not recruiting | CanSino Biologics Inc. | 780 | 2025-03-23 | 2025-08-15 |
| A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp)), 23-valent Pneumococcal Polysaccharide Vaccine (PPV23), Tdcp - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | CanSino Biologics Inc. | 1820 | 2024-12-20 | 2026-08-26 |
| A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants altSonflex1-2-3 Dose A, altSonflex1-2-3 Dose B, altSonflex1-2-3 Dose C - Diarrhoea | Phase 2 | Completed | GlaxoSmithKline | 200 | 2024-11-13 | 2026-01-30 |
| Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial Biopsy, Biospecimen Collection, Computed Tomography - Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | Recruiting | Mayo Clinic | 78 | 2024-11-12 | 2026-10-02 |
| PFAS Exposure and Immune Response to Vaccination in Adults TENIVAC - Innate Inflammatory Response, Vaccination | Phase 4 | Completed | Rutgers, The State University of New Jersey | 20 | 2024-11-04 | 2025-12-30 |
| Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers RSVt vaccine, Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccine, Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine - RSV Immunization | Phase 3 | Terminated | Sanofi Pasteur, a Sanofi Company | 2226 | 2024-05-13 | 2026-10-05 |
| Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine Tetanus Toxoid (Adsorbed) - Tetanus, Tetanus Vaccine | Phase 3 | Completed | Beijing Minhai Biotechnology Co., Ltd | 1240 | 2024-02-29 | 2026-08-03 |
| Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed), Diphtheria, tetanus and acellular pertussis combined vaccine (adsorbed), Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine (adsorbed) and Haemophilus influenzae type b conjugate vaccine - Healthy Volunteers | Phase 3 | Recruiting | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1584 | 2023-12-21 | 2024-04-03 |
| A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp), 23-Valent Pneumococcal Polysaccharide Vaccine（PPV23）, Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT) - Diphtheria, Tetanus | Phase 1 | Completed | CanSino Biologics Inc. | 180 | 2023-12-06 | 2026-08-07 |
| Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy Vaccines against: Diphtheria, tetanus, pertussis, polio, haemophilus influenza type b, varicella and measles - Vaccine Immunity in CAR-T Cell Therapy Recipients | Recruiting | Insel Gruppe AG, University Hospital Bern | 80 | 2023-11-14 | 2024-03-27 | |
| A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP), Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaP, Diphtheria,tetanus,pertussis(acellular,component),Inactivated polio vaccine(adsorbed）and Haemophilus influenzae type b conjugate vaccine,adsorbed,DTaP-IPV-Hib - Diphtheria, Tetanus and Acellular Pertussis | Phase 3 | Active not recruiting | CanSino Biologics Inc. | 2520 | 2023-08-11 | 2025-03-17 |
| Immunosuppression and COVID-19 Boosters diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine - COVID-19 | Phase 3 | Recruiting | Kirby Institute | 320 | 2023-07-21 | 2026-02-24 |
Showing 20 of 141. Sign in to see all of them.
Tetanus (61) · Diphtheria (51) · Whooping Cough (42) · Poliomyelitis (14) · Meningococcal Infections (12) · Haemophilus Infections (10) · HIV Infections (7) · Hepatitis B (7) · Meningitis (6) · Glioblastoma (4) · Pneumococcal Infections (4) · Arthritis, Rheumatoid (3) · Glioma (3) · Astrocytoma (2) · Bacterial Infections (2)
Sanofi Pasteur, a Sanofi Company (34) · GlaxoSmithKline (15) · National Institute of Allergy and Infectious Diseases (NIAID) (10) · Novartis Vaccines (7) · CanSino Biologics Inc. (6) · Sanofi (6) · Bristol-Myers Squibb (3) · National Cancer Institute (NCI) (3) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (2) · Gary Archer Ph.D. (2) · Institute of Medical Biology, Chinese Academy of Medical Sciences (2) · London School of Hygiene and Tropical Medicine (2) · Masonic Cancer Center, University of Minnesota (2) · Merck Sharp & Dohme LLC (2) · Novartis (2)
United States (56) · China (21) · Canada (16) · United Kingdom (10) · Puerto Rico (9) · Spain (7) · South Korea (6) · Australia (5) · Germany (5) · Switzerland (5) · Belgium (4) · Costa Rica (4) · France (4) · Mexico (4) · Netherlands (4)
Aimee R Kreimer (2) · Adrian Hill (1) · Aimee Kreimer (1) · Aitana Juan Giner, MSc (1) · Alassane Dicko, Professor (1) · Brendan Curti, MD (1)
PMID 41276263, PMID 15882526, PMID 16511379, PMID 16816555, PMID 17425783, PMID 17938165, PMID 18182599, PMID 18676757, PMID 18752430, PMID 19095033, PMID 19117896, PMID 19209097, PMID 19663708, PMID 20657177, PMID 21219984, PMID 22001281, PMID 22094635, PMID 22115634, PMID 22273029, PMID 22693229, PMID 23566945, PMID 24177180, PMID 24189367, PMID 24794369, PMID 25401780, PMID 25540274, PMID 25762141, PMID 25872570, PMID 25882172, PMID 27388557, PMID 27828786, PMID 27879555, PMID 27939054, PMID 28411277, PMID 29116597, PMID 29172945, PMID 29438562, PMID 29573876, PMID 30010773, PMID 30044050, PMID 30148186, PMID 30278056, PMID 30281066, PMID 30471953, PMID 30686952, PMID 30877773, PMID 31301919, PMID 31919278, PMID 31999736, PMID 32078808
2017 (2), 2019 (2), 2023 (2), 2004 (1), 2014 (1), 2015 (1), 2016 (1), P30CA012197 (1), R01CA175517 (1), R42CA153845 (1), U01AI141990 (1), U19AI181103 (1)